I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Comparison of different methods for defining hyperprogressi..:
Rocha, Pedro P
;
Ramal, Didac
;
Ripoll, Enric
...
Comparison of different methods for defining hyperprogressive disease in NSCLC. JTO Clin Res Rep. 2020 Oct 28; 2(1): 100115. DOI:10.1016/j.jtocrr.2020.100115. ,
Link:
http://hdl.handle.net/10230/53601
RT Journal T1 <Title>Comparison of different methods for defining hyperprogressive disease in NSCLC</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftupompeufabra:oai:repositori.upf.edu:10230_53601&Exemplar=1&LAN=DE A1 Rocha, Pedro P A1 Ramal, Didac A1 Ripoll, Enric A1 Moliner, Laura A1 Corbera-Lloret, Alex A1 Hardy-Werbin, Max A1 Orrillo, Mayra A1 Taus García, Álvaro A1 Zuccarino, Flavio A1 Gibert Fernandez, Joan 1988- A1 Perera Bel, Júlia A1 Casadevall Aguilar, David A1 Arriola Aperribay, Edurne PB Elsevier K1 Chemotherapy K1 Hyperprogressive disease K1 Immune checkpoint inhibitors K1 NSCLC JF Comparison of different methods for defining hyperprogressive disease in NSCLC. JTO Clin Res Rep. 2020 Oct 28; 2(1): 100115. DOI:10.1016/j.jtocrr.2020.100115 LK http://hdl.handle.net/10230/53601 DO http://hdl.handle.net/10230/53601 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
